Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer
Open Access
- 7 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (19) , 4595-4603
- https://doi.org/10.1182/blood-2008-07-165456
Abstract
Tumor necrosis factor (TNF) receptor–associated factor 3 (TRAF3) regulates both innate and adaptive immunity by modulating signaling by Toll-like recKeywords
This publication has 29 references indexed in Scilit:
- Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Critical Regulator of B Cell Homeostasis in Secondary Lymphoid OrgansImmunity, 2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- Rescue of TRAF3-null mice by p100 NF-κB deficiencyThe Journal of Experimental Medicine, 2006
- Regulation of antiviral responses by a direct and specific interaction between TRAF3 and CardifThe EMBO Journal, 2006
- Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral responseNature, 2005
- Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6Nature, 2005
- TRAF2 Differentially Regulates the Canonical and Noncanonical Pathways of NF-κB Activation in Mature B CellsImmunity, 2004
- Granzyme Release and Caspase Activation in Activated Human T-LymphocytesJournal of Biological Chemistry, 1998
- Induction of Plasmacytomas With Silicone Gel Genetically Susceptible Strains of MiceJNCI Journal of the National Cancer Institute, 1994